| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 89.73× | 89.73× | 71.89× | 63.74× | 82.38× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.21× | 0.21× | 0.24× | 0.24× | 0.19× | ||
| 0.29× | 0.29× | 0.01× | −0.13× | 0.01× | ||
| 0.20× | 0.20× | 0.01× | −0.10× | 0.01× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 82.38 | 63.74 | 71.89 | 89.73 | 89.73 | |
| Asset Turnover | 0.19 | 0.24 | 0.24 | 0.21 | 0.21 | |
| Cash Conversion (CFO/Net Income) | 0.01 | -0.13 | 0.01 | 0.29 | 0.29 | |
| CFO/EBITDA | 0.01 | -0.10 | 0.01 | 0.20 | 0.20 |